Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications.
Fiche publication
Date publication
août 2000
Journal
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr WESTEEL Virginie
Tous les auteurs :
Andre F, Grunenwald D, Pignon JP, Dujon A, Pujol JL, Brichon PY, Brouchet L, Quoix E, Westeel V, Le Chevalier T
Lien Pubmed
Résumé
Patients who suffer from non-small-cell lung cancer (NSCLC) with ipsilateral mediastinal lymph node involvement (N2) belong to a heterogeneous subgroup of patients. We analyzed the prognosis of patients with resected N2 NSCLC to propose homogeneous patient subgroups.
Mots clés
Adolescent, Adult, Aged, Aged, 80 and over, Analysis of Variance, Carcinoma, Non-Small-Cell Lung, classification, Chemotherapy, Adjuvant, Female, Humans, Lung Neoplasms, classification, Lymphatic Metastasis, Male, Middle Aged, Neoplasm Staging, Preoperative Care, Prognosis, Proportional Hazards Models, Retrospective Studies, Survival Analysis, Survival Rate
Référence
J. Clin. Oncol.. 2000 Aug;18(16):2981-9